Clearside Biomedical, Inc. (CLSD): Price and Financial Metrics


Clearside Biomedical, Inc. (CLSD)

Today's Latest Price: $2.52 USD

0.25 (-9.03%)

Updated Feb 14 6:55pm

Add CLSD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CLSD Stock Summary

  • CLSD's price/sales ratio is 381.54; that's higher than the P/S ratio of 99.19% of US stocks.
  • Revenue growth over the past 12 months for Clearside Biomedical Inc comes in at 374.55%, a number that bests 98.15% of the US stocks we're tracking.
  • The volatility of Clearside Biomedical Inc's share price is greater than that of 97.2% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to CLSD, based on their financial statements, market capitalization, and price volatility, are GLMD, LIFE, LJPC, CUE, and OMER.
  • Visit CLSD's SEC page to see the company's official filings. To visit the company's web site, go to www.clearsidebio.com.
CLSD Daily Price Range
CLSD 52-Week Price Range

CLSD Stock Price Chart More Charts


CLSD Price/Volume Stats

Current price $2.52 52-week high $4.13
Prev. close $2.77 52-week low $0.56
Day low $2.49 Volume 1,000,200
Day high $2.77 Avg. volume 1,561,797
50-day MA $2.59 Dividend yield N/A
200-day MA $1.41 Market Cap 111.92M

Clearside Biomedical, Inc. (CLSD) Company Bio


Clearside Biomedical, a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. The company was founded in 2011 and is based in Alpharetta, Georgia


CLSD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CLSD Latest Social Stream


Loading social stream, please wait...

View Full CLSD Social Stream

CLSD Price Returns

1-mo -11.27%
3-mo 149.50%
6-mo 223.66%
1-year 59.49%
3-year -67.14%
5-year N/A
YTD -13.10%
2019 171.03%
2018 -84.71%
2017 -21.70%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6862 seconds.